FFA
BLTE

Farther Finance Advisors’s Belite Bio BLTE Stock Holding History

Farther Finance Advisors’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616 Sell
4
-11
-73% -$1.69K ﹤0.01% 5492
2026
Q1 		$2.51K Sell
15
-86
-85% -$14.5K ﹤0.01% 4809
2025
Q4 		$16.2K Buy
+101
New +$12K ﹤0.01% 3583

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Farther Finance Advisors's BLTE Position: Q2 2026 in Review

Farther Finance Advisors reduced its Belite Bio (BLTE) stake by 73% in Q2 2026, selling an estimated $1.69K and leaving 4 shares worth $616. The position accounts for ﹤0.01% of the portfolio, ranked #5492.

Farther Finance Advisors first reported a position in BLTE in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.2K in Q4 2025. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Farther Finance Advisors held 4 shares of Belite Bio worth $616 as of Q2 2026.
  • Farther Finance Advisors sold 11 Belite Bio shares in Q2 2026, an estimated $1.69K.
  • Belite Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5492 holding.
  • Farther Finance Advisors first reported a position in Belite Bio in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Belite Bio position peaked at $16.2K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.